A-Share Listed Biological Products Companies-Profiles and Financial Data

A-Share Listed Biological Products Companies-Profiles and Financial Data


  • Products Id :- CRI1703487
  • |
  • Pages: 160
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

In China, biological products include: bacterial vaccines (containing toxoid), viral vaccines, antitoxin and antiserum, blood products, cytokine, growth factors, enzyme, in vivo and in vitro diagnostic products, and other biological active preparations.

According to CRI, fast economic growth and residents' increasing income have pushed up people's medical expenses. China's biological products market outperforms the global average. In China, the market size exceeded CNY 130 billion in 2016, but its share in the pharmaceutical market was less than 10%, far below that in developed countries.

In the Thirteenth Five-Year Plan (2016-2020), biotechnological pharmaceuticals, new vaccines, new cell therapy preparations and other innovative pharmaceuticals were listed among the priorities of the biomedicine industry. It is expected that in the next few years, biotechnological advances and favorable policies will facilitate fast growth of the biological product industry.

In this report, CRI analyzes 38 biological products manufacturers listed in A-share market in China.

The report is composed of two parts: the first part is enterprise profiles and the second part is the operation status of these enterprises in the recent decade (presently 2006 to 2016, we will update it to the latest as time goes by).

The operation status is demonstrated from the following perspectives: (1)financial indexes, such as earnings per share, book value per share (BPS), sales per share, net cash flow per share, return on net worth and debt to asset ratio; (2) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (3) indexes on the income statement, such as revenue, operating profit, net profit and EBIT; (4) indexes on the balance sheet, such as liquid asset, fixed asset, current liability, non-current liability, capital reserve and shareholders' equity.

(1) Financial Indexes

Earnings per Share

Book Value per Share (BPS)

Sales per Share (SPS)

Net Cash Flow per Share from Operations

Net Cash Flow per Share (CNY)

Return on Net Worth

Net Profit Margin on Total Assets

Return on Invested Capital (ROIC) (%)

Gross Profit Margin on Sales (%)

Net Profit Margin on Sales (%)

EBIT Margin (%)

EBITDA Margin (%)

Debt to Asset Ratio (%)

Total Asset Turnover (times)

Cash/Operating Income Received from Sales of Goods or Services

YOY Growth Rate of Operating Revenue (%)

YOY Growth Rate of Operating Profit (%)

YOY Growth Rate of Net Profit Attributable to Shareholders of Parent Company (%)

(2) Summary of Income Statement

Gross Revenue (CNY, million)

Total Operating Costs (CNY, million)

Revenue (CNY, million)

Operating Profit (CNY, million)

Total Profit (CNY, million)

Net Profit (CNY, million)

Net Profit Attributable to Shareholders of Parent Company (CNY, million)

Non-recurring Items (CNY, million)

Net Profit Deducting Non-recurring Items (CNY, million)

R&D Costs (CNY, million)

Earnings Before Interest and Tax (EBIT) (CNY, million)

Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) (CNY, million)

(3) Summary of Balance Sheet

Liquid Asset (CNY, million)

Fixed Asset (CNY, million)

Long-term Equity Investment

Total Assets (CNY, million)

Liquid Liability (CNY, million)

Non-current Liability (CNY, million)

Total Liability (CNY, million)

Capital Reserve (CNY, million)

Surplus Reserve (CNY, million)

Undistributed Profit (CNY, million)

Shareholders' Equity (CNY, million)

Equity Attributable to Shareholders of Parent Company (CNY, million)

(4) Summary of Cash Flow Statement

Cash Received from Sales of Goods and Services (CNY, million)

Cash Flow from Operations (CNY, million)

Cash Paid to Purchase Fixed Assets, Intangible Assets and Other Long-term Assets (CNY, million)

Cash Paid for Investments (CNY, million)

Cash Flow from Investments (CNY, million)

Cash Received from Investors (CNY, million)

Cash Received from Borrowings (CNY, million)

Cash Flow from Financing (CNY, million)

Net Increase of Cash and Cash Equivalents (CNY, million)

Cash and Cash Equivalents, End of Period (CNY, million)

Depreciation and Amortization (CNY, million)



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Companies in the report:

1 Ginwa Enterprise (Group) Inc. (600080.SH)

2 Beijing Tiantan Biological Products Co., Ltd. (600161.SH)

3 Shanghai Fosun Pharmaceutical Co., Ltd. (600196.SH)

4 Bluestar Adisseo Company (600299.SH)

5 Shanghai Jiaoda Onlly Co., Ltd. (600530.SH)

6 Zhongyuan Union Cell & Gene Engineering Corp., Ltd. (600645.SH)

7 Zhejiang Qianjiang Biochemical Co., Ltd. (600796.SH)

8 Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SH)

9 Autobio Diagnostics Co., Ltd. (603658.SH)

10 Wuhan Thalys Medical Technology Inc. (603716.SH)

11 Shenzhen Cau Technology Co., Ltd. (000004.SZ)

12 Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ)

13 Zhenxing Biopharmaceutical & Chemical Inc. (000403.SZ)

14 Jiangsu Sihuan Bioengineering Co., Ltd. (000518.SZ)

15 Changchun High-Tech Industry Co., Ltd. (000661.SZ)

16 Hualan Biological Engineering Co., Ltd. (002007.SZ)

17 Shanghai Kehua Bio-engineering Co., Ltd. (002022.SZ)

18 DAAN Gene Co., Ltd. of Sun Yat-sen University (002030.SZ)

19 Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)

20 Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)

21 Shandong Sinobioway Biomedicine Co., Ltd. (002581.SZ)

22 Changsheng Bio-technology Co., Ltd. (002680.SZ)

23 Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)

24 Chongqing Chifei Biological Products Co., Ltd. (300122.SZ)

25 Walvax Biotechnology Co., Ltd. (300142.SZ)

26 Staidson (Beijing) Biopharmaceuticals Co., Ltd. (300204.SZ)

27 Baotou Dongbao Bio-Tech Co., Ltd. (300239.SZ)

28 Beijing Leadman Biochemistry Co., Ltd. (300289.SZ)

29 Jiangxi Boya Bio-pharmaceutical Co., Ltd. (300294.SZ)

30 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)

31 Guangdong Vtr Bio-Tech Co., Ltd. (300381.SZ)

32 Beijing Strong Biotechnologies, Inc. (300406.SZ)

33 Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ)

34 Medicalsystem Biotechnology Co., Ltd. (300439.SZ)

35 Sichuan Maccura Biotechnology Co., Ltd. (300463.SZ)

36 Guangzhou Wondfo Biotech Co., Ltd. (300482.SZ)

37 Shandong Sito Bio-technology Co., Ltd. (300583.SZ)

38 Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ)

Single User License:
Only for single user or inner small group. The report cannot be printed or copied.

Corporate User License:
It can be used for all staff of the company. The report can be printed and copied.

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

1 Ginwa Enterprise (Group) Inc. (600080.SH), 2 Beijing Tiantan Biological Products Co., Ltd. (600161.SH), 3 Shanghai Fosun Pharmaceutical Co., Ltd. (600196.SH), 4 Bluestar Adisseo Company (600299.SH), 5 Shanghai Jiaoda Onlly Co., Ltd. (600530.SH), 6 Zhongyuan Union Cell & Gene Engineering Corp., Ltd. (600645.SH), 7 Zhejiang Qianjiang Biochemical Co., Ltd. (600796.SH), 8 Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SH), 9 Autobio Diagnostics Co., Ltd. (603658.SH), 10 Wuhan Thalys Medical Technology Inc. (603716.SH), 11 Shenzhen Cau Technology Co., Ltd. (000004.SZ), 12 Shenzhen Neptunus Bioengineering Co., Ltd. (000078.SZ), 13 Zhenxing Biopharmaceutical & Chemical Inc. (000403.SZ), 14 Jiangsu Sihuan Bioengineering Co., Ltd. (000518.SZ), 15 Changchun High-Tech Industry Co., Ltd. (000661.SZ), 16 Hualan Biological Engineering Co., Ltd. (002007.SZ), 17 Shanghai Kehua Bio-engineering Co., Ltd. (002022.SZ), 18 DAAN Gene Co., Ltd. of Sun Yat-sen University (002030.SZ), 19 Beijing SL Pharmaceutical Co., Ltd. (002038.SZ), 20 Shanghai RAAS Blood Products Co., Ltd. (002252.SZ), 21 Shandong Sinobioway Biomedicine Co., Ltd. (002581.SZ), 22 Changsheng Bio-technology Co., Ltd. (002680.SZ), 23 Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ), 24 Chongqing Chifei Biological Products Co., Ltd. (300122.SZ), 25 Walvax Biotechnology Co., Ltd. (300142.SZ), 26 Staidson (Beijing) Biopharmaceuticals Co., Ltd. (300204.SZ), 27 Baotou Dongbao Bio-Tech Co., Ltd. (300239.SZ), 28 Beijing Leadman Biochemistry Co., Ltd. (300289.SZ), 29 Jiangxi Boya Bio-pharmaceutical Co., Ltd. (300294.SZ), 30 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ), 31 Guangdong Vtr Bio-Tech Co., Ltd. (300381.SZ), 32 Beijing Strong Biotechnologies, Inc. (300406.SZ), 33 Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ), 34 Medicalsystem Biotechnology Co., Ltd. (300439.SZ), 35 Sichuan Maccura Biotechnology Co., Ltd. (300463.SZ), 36 Guangzhou Wondfo Biotech Co., Ltd. (300482.SZ), 37 Shandong Sito Bio-technology Co., Ltd. (300583.SZ), 38 Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) ,

biological products

select a license

Single User License
USD 1600 INR 103648
Hard Copy License
USD 1600 INR 103648
Corporate User License
USD 2400 INR 155472

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com